Is Bortezomib a Rare Cause of Acute Pancreatitis?
Abstract
No abstract available.
Image: Proteasome inhibitor bortezomib bound to an assembled yeast proteasome core (PDB ID 2F16). (From Wikimedia Commons).
Downloads
References
Elouni B, Ben Salem C, Zamy M, Sakhri J, Bouraoui K, Biour M. Bortezomib-induced acute pancreatitis (Letter). JOP. J pancreas (Online) 2010; 11:275-6.
Kane RC, Bross PF, Farrell AT, Pazdur R. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist. 2003;8:508-13.
Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:143-55.
Mihaila RG. A possible rare complication of bortezomib treatment: acute pancreatitis. Acta Medica Transilvanica 2013; 2:269-71.

Copyright (c) 2014 Tevfik Solakoglu, Mustafa Akar, Tugba Aktan Kosker, Semnur Buyukasik, Osman Ersoy

This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.